Arama Sonuçları - Bo Lagerqvist

Sonuçları Daraltın
  1. 1
    FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease

    FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease Yazar: Bo Lagerqvist

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms

    Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms Yazar: Bo Lagerqvist, Christer Sylvén, Anders Waldenström

    Baskı/Yayın Bilgisi 1992
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain?

    Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Yazar: Nina Johnston, Karin Schenck‐Gustafsson, Bo Lagerqvist

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Renal failure in 57925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media

    Renal failure in 57925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media Yazar: P. Liss, Pontus B. Persson, Peter Hansell, Bo Lagerqvist

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy

    Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy Yazar: Bertil Lindahl, Erik Diderholm, Bo Lagerqvist, Per Venge, Lars Wallentin

    Baskı/Yayın Bilgisi 2001
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality

    Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality Yazar: Kai M. Eggers, Bo Lagerqvist, Per Venge, Lars Wallentin, Bertil Lindahl

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Differences in Restenosis Rate With Different Drug-Eluting Stents in Patients With and Without Diabetes Mellitus

    Differences in Restenosis Rate With Different Drug-Eluting Stents in Patients With and Without Diabetes Mellitus Yazar: Ole Fröbert, Bo Lagerqvist, J. Carlsson, Johan Lindbäck, Ulf Stenestrand, Stefan James

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden

    Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden Yazar: Bo Lagerqvist, Stefan James, Ulf Stenestrand, Johan Lindbäck, Tage Nilsson, Lars Wallentin

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

    Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Yazar: Sasha Koul, J. G. Smith, Fredrik Scherstén, Stefan James, Bo Lagerqvist, David Erlinge

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention

    Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention Yazar: Axel Åkerblom, Stefan James, Michail Koutouzis, Bo Lagerqvist, Ulf Stenestrand, Bodil Svennblad, Jonas Oldgren

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer

    Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer Yazar: Greger Nilsson, Lars Holmberg, Hans Garmo, Olov Duvernoy, Iwar Sjögren, Bo Lagerqvist, Carl Blomqvist

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)

    Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Ev... Yazar: Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, Henrik Renlund, Lars Wallentin, Stefan James, Tomas Jernberg

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment

    Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment Yazar: Lene Holmvang, Peter Clemmensen, Bertil Lindahl, Bo Lagerqvist, Per Venge, Galen S. Wagner, Lars Wallentin, Peer Grande

    Baskı/Yayın Bilgisi 2003
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

    Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAA... Yazar: Ulf Stenestrand, Stefan James, Johan Lindbäck, Ole Fröbert, J. Carlsson, Fredrik Scherstén, Tage Nilsson, Bo Lagerqvist

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden

    Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden Yazar: Stefan James, Ulf Stenestrand, Johan Lindbäck, J. Carlsson, Fredrik Scherstén, Tage Nilsson, Lars Wallentin, Bo Lagerqvist

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Clinical Impact of Second-Generation Everolimus-Eluting Stent Compared With First-Generation Drug-Eluting Stents in Diabetes Mellitus Patients

    Clinical Impact of Second-Generation Everolimus-Eluting Stent Compared With First-Generation Drug-Eluting Stents in Diabetes Mellitus Patients Yazar: Elvin Kedhi, Marc E. Gomes, Bo Lagerqvist, J. G. Smith, Elmir Ömerovic, Stefan James, Jan Harnek, Göran Olivecrona

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

    Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplas... Yazar: Giovanna Sarno, Bo Lagerqvist, Ole Fröbert, Johan Nilsson, Göran Olivecrona, Elmir Ömerovic, Nawzad Saleh, Dimitris Venetzanos, Stefan James

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry

    Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry Yazar: Oskar Angerås, Per Albertsson, Kristjan Karason, Truls Råmunddal, Göran Matejka, Stefan James, Bo Lagerqvist, Annika Rosengren, Elmir Ömerovic

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry

    Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry Yazar: Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, Henrik Renlund, Elmir Ömerovic, David Erlinge, Lars Wallentin, Stefan James, Tomas Jernberg

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and Prognosis

    Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and Prognosis Yazar: Anna M. Nordenskjöld, Bo Lagerqvist, Tomasz Baron, Tomas Jernberg, Nermin Hadziosmanovic, Harmony R. Reynolds, Per Tornvall, Bertil Lindahl

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: